| Summer Lynn Johnson, | |
|
7005 Woodway Dr Ste 101, Waco, TX 76712 | |
| (254) 741-6641 | |
| Not Available |
| Full Name | Summer Lynn Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 7005 Woodway Dr Ste 101, Waco, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821595950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | AP137243 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP137243 (Texas) | Primary |
| Entity Name | Falls Community Hospital And Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093743783 PECOS PAC ID: 8527959816 Enrollment ID: O20040324000971 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
Subcutaneous immunoglobulin therapy, administered at home, is an acceptable substitute for hospital-based intravenous immunoglobulin in patients with immune deficiencies, according to recent findings published in the Journal of Clinical Immunology.
In a study from Uppsala University, published in the American journal JAMA Cardiology, the fatty acid linoleic acid (Omega 6) in subcutaneous adipose tissue was linked to lower mortality among older men followed over a 15-year period.
› Verified 2 days ago
| Entity Name | Emergency Associates Of Central Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215418280 PECOS PAC ID: 6800147216 Enrollment ID: O20180925001294 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
Subcutaneous immunoglobulin therapy, administered at home, is an acceptable substitute for hospital-based intravenous immunoglobulin in patients with immune deficiencies, according to recent findings published in the Journal of Clinical Immunology.
In a study from Uppsala University, published in the American journal JAMA Cardiology, the fatty acid linoleic acid (Omega 6) in subcutaneous adipose tissue was linked to lower mortality among older men followed over a 15-year period.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Summer Lynn Johnson, 3115 Pitchfork Cir, Belton, TX 76513-1060 Ph: (125) 449-3520 | Summer Lynn Johnson, 7005 Woodway Dr Ste 101, Waco, TX 76712 Ph: (254) 741-6641 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
Subcutaneous immunoglobulin therapy, administered at home, is an acceptable substitute for hospital-based intravenous immunoglobulin in patients with immune deficiencies, according to recent findings published in the Journal of Clinical Immunology.
In a study from Uppsala University, published in the American journal JAMA Cardiology, the fatty acid linoleic acid (Omega 6) in subcutaneous adipose tissue was linked to lower mortality among older men followed over a 15-year period.
› Verified 2 days ago